Hos postmenopausale kvinder med osteoporose reducerer EVISTA forekomsten af vertebrale frakturer, bevarer knoglemassen og øger knoglemineraltætheden (BMD).
In postmenopausal women with osteoporosis, EVISTA reduces the incidence of vertebral fractures, preserves bone mass and increases bone mineral density (BMD).